Trinidad and Tobago
Tuberculosis profile
| High HIV burden |
Population  2012 1.3 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.028 (0.028–0.028) 2.1 (2.1–2.1)
Mortality (HIV+TB only) 0.01 (<0.01–0.014) 0.78 (0.66–1)
Prevalence  (includes HIV+TB) 0.37 (0.17–0.65) 28 (13–48)
Incidence  (includes HIV+TB) 0.32 (0.28–0.36) 24 (21–27)
Incidence (HIV+TB only) 0.083 (0.073–0.094) 6.2 (5.5–7)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 167 (63) Relapse 7 (13)
Smear-negative 78 (29) Treatment after failure 6 (11)
Smear-unknown / not done 3 (1) Treatment after default 24 (44)
Extrapulmonary 19 (7) Other 17 (31)
Other 0 (0)      
Total new 267   Total retreatment 54  
           
Other (history unknown) 0        
Total new and relapse 274   Total cases notified 321  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.0 3.5 1.1
Age < 15 2 2 3
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 72   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 65  
Retreatment 35  
TB/HIV 2012 Number (%)
TB patients with known HIV status 311 (97)
HIV-positive TB patients 82 (26)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 23 (28)
HIV-positive TB patients on antiretroviral therapy (ART) 24 (29)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.8 (0.9–2.6) 12 (9.2–15)
MDR-TB cases among notified pulmonary
TB cases
5 (2–6) 6 (5–8)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 6 (2%) 10 (19%) 16
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions) 1
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data